Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04662970 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology

Study acronym: NICE CRT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Dec 31, 2022 to Dec 31, 2025
    • Study completion date: Dec 31, 2023 to Dec 31, 2025
    v3
  4. Primary completion date: Dec 31, 2021 to Dec 31, 2022
    • Study completion date: Dec 31, 2022 to Dec 31, 2023
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology
Trial Details
NCT Number NCT04662970
Lead Sponsor Medical University Innsbruck
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov